DrSasi Sasikaran

Operations Manager - Clinical Research

School of Public Health - Faculty of Medicine

  • Operations Manager - Clinical Research
    School of Public Health - Faculty of Medicine
  • Stadium House, 68 Wood Lane, Stadium House, White City Campus, United Kingdom

BIO

Dr Thiagarajah Sasikaran (Sasi) works as one of the Operations Managers in the division of Surgery within the UKCRC-registered Imperial Clinical Trials Unit (ICTU). He joined Imperial College in 2002 and has extensive experience in the delivery of large-scale, multi-centre, international clinical trials. His main interest remains focused on innovative trial design and delivery, to enable key questions to be answered quickly and robustly. Adaptive trial designs include multi-arm, multi-stage RCTs (MAMS) and Trials WithIn Cohorts (TWICS).

Sasi currently oversees the full trial management process for the ICTU Surgery portfolio of studies including ATLAS (Approaches To Long-Term Active Surveillance), PACIFIC (Prostate Assessment using Comparative Interventions – Fast mri and Image-fusion for Cancer), EARNEST (Early Aortic Repair in patients Needing Endovascular/open Surgery for Type B Aortic Dissection) and PRADA II (Pre-operative Radiotherapy And DIEP flAP Reconstruction II Trial) from applying for funding through to reporting of results.

He has previously managed and delivered numerous multi-centre randomised clinical trials listed below: EMBIO (Left gastric artery embolisation (LGAE) for weight loss in patients with BMI 35-50 kg/m2), CHRONOS (Comparative Health Research Outcomes of Novel Surgery in prostate cancer), AVATAR- AF trial (Ablation Versus Anti-arrhythmic Therapy for reducing All hospital episodes from Recurrent Atrial Fibrillation), SERCA-LVAD trial (Investigation of the safety and feasibility of SERCA2a gene transfer in patients with chronic heart failure and a left ventricular assist device), AARDVARK (Aortic Aneurysmal Regression of Dilation: Value of Ace-inhibition on RisK), FOURIER trial (Further Cardiovascular Outcomes Research with PCSK9 inhibition in subjects with Elevated Risks), CVLPRI-t trial (Complete Versus Lesion-only PRimary PCI Pilot) and PILL Pilot (A randomised placebo-controlled trial of fixed-dose combination medication in people at raised risk of cardiovascular disease).

NON-ACADEMIC POSITIONS

  • Operations Manager - Clinical Trials
    Imperial College London, Imperial Clinical Trials Unit, School of Public Health, London, United Kingdom9 Dec 2002 - present

DEGREES

  • PhD
    Kingston University, Kingston, United Kingdom

FACULTY

  • Faculty of Medicine

POSITION NAME

  • Operations Manager - Clinical Research

FIELDS OF RESEARCH